Search Results - "Nogués Xavier"

Refine Results
  1. 1
  2. 2
  3. 3

    Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid‐Induced Osteoporosis by Mellibovsky, Leonardo, Prieto‐Alhambra, Daniel, Mellibovsky, Fernando, Güerri‐Fernández, Roberto, Nogués, Xavier, Randall, Connor, Hansma, Paul K, Díez‐Perez, Adolfo

    Published in Journal of bone and mineral research (01-09-2015)
    “…ABSTRACT Glucocorticoids, widely used in inflammatory disorders, rapidly increase bone fragility and, therefore, fracture risk. However, common bone…”
    Get full text
    Journal Article Publication
  4. 4

    Functional Analyses of Four CYP1A1 Missense Mutations Present in Patients with Atypical Femoral Fractures by Ugartondo, Nerea, Martínez-Gil, Núria, Esteve, Mònica, Garcia-Giralt, Natàlia, Roca-Ayats, Neus, Ovejero, Diana, Nogués, Xavier, Díez-Pérez, Adolfo, Rabionet, Raquel, Grinberg, Daniel, Balcells, Susanna

    “…Osteoporosis is the most common metabolic bone disorder and nitrogen-containing bisphosphonates (BP) are a first line treatment for it. Yet, atypical femoral…”
    Get full text
    Journal Article
  5. 5

    Genetics and Genomics of SOST : Functional Analysis of Variants and Genomic Regulation in Osteoblasts by Martínez-Gil, Núria, Roca-Ayats, Neus, Cozar, Mónica, Garcia-Giralt, Natàlia, Ovejero, Diana, Nogués, Xavier, Grinberg, Daniel, Balcells, Susanna

    “…encodes the sclerostin protein, which acts as a key extracellular inhibitor of the canonical Wnt pathway in bone, playing a crucial role in skeletal…”
    Get full text
    Journal Article
  6. 6

    Bone tissue quality in patients with monoclonal gammopathy of uncertain significance by Orduna, Guillermina, Mellibovsky, Leonardo, Abella, Eugenia, Nogués, Xavier, Granero, Roser, García-Giralt, Natalia, Pineda-Moncusí, Marta, Güerri-Fernández, Roberto, Prieto-Alhambra, Daniel, Díez-Pérez, Adolfo

    Published in Journal of bone and mineral metabolism (01-07-2020)
    “…Introduction Monoclonal gammopathy of uncertain significance (MGUS) is highly prevalent in older adults and affects bone structure, with osteoporosis and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Increased hip fracture and mortality in chronic kidney disease individuals: The importance of competing risks by Pérez-Sáez, María José, Prieto-Alhambra, Daniel, Barrios, Clara, Crespo, Marta, Redondo, Dolores, Nogués, Xavier, Díez-Pérez, Adolfo, Pascual, Julio

    Published in Bone (New York, N.Y.) (01-04-2015)
    “…Abstract Background Many studies have shown a correlation between chronic kidney disease (CKD) and fracture. However, increased mortality in CKD patients is a…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort by Martínez-Laguna, Daniel, Tebé, Cristian, Nogués, Xavier, Kassim Javaid, M, Cooper, Cyrus, Moreno, Victor, Diez-Perez, Adolfo, Collins, Gary S, Prieto-Alhambra, Daniel

    Published in PloS one (07-09-2018)
    “…An increased fracture risk has been described as a complication of Type 2 diabetes mellitus (T2DM). Clinical prediction models for general population have a…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Current situation of shared decision making in osteoporosis: A comprehensive literature review of patient decision aids and decision drivers by Nogués, Xavier, Carbonell, María Cristina, Canals, Laura, Lizán, Luis, Palacios, Santiago

    Published in Health science reports (01-11-2022)
    “…Background and Aims Osteoporosis is a systemic skeletal disease characterized by low bone mass and microstructural deterioration of bone tissues, resulting in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study by Garcia-Giralt, Natalia, Rodríguez-Sanz, María, Prieto-Alhambra, Daniel, Servitja, Sonia, Torres-del Pliego, Elisa, Balcells, Susana, Albanell, Joan, Grinberg, Daniel, Diez-Perez, Adolfo, Tusquets, Ignasi, Nogués, Xavier

    Published in Breast cancer research and treatment (01-07-2013)
    “…A major side effect of aromatase inhibitor (AI) therapy is AI-related arthralgia (AIA), which often leads to therapy discontinuation. We aimed to identify…”
    Get full text
    Journal Article
  16. 16
  17. 17

    TBS and BMD at the end of AI-therapy: A prospective study of the B-ABLE cohort by María, Rodríguez-Sanz, Marta, Pineda-Moncusí, Sonia, Servitja, Natalia, Garcia-Giralt, Tamara, Martos, Ignasi, Tusquets, Maria, Martínez-García, Jaime, Rodriguez-Morera, Adolfo, Diez-Perez, Joan, Albanell, Xavier, Nogués

    Published in Bone (New York, N.Y.) (01-11-2016)
    “…Abstract Introduction Patients with breast cancer under aromatase inhibitor (AI) treatment often develop osteoporosis and their average bone loss rate is twice…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20